Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders
- PMID: 16401147
Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders
Abstract
Autism and other pervasive developmental disorders (PDDs) are associated with various dysfunctional and problematic behaviors, in addition to the core features of language and social skills dysfunction that define these conditions. Although there is currently no pharmacologic cure for the core features of PDDs, some of the behavioral symptoms may be treated pharmacologically. In addition to relieving some of the daily stress in the lives of patients and their families, improvement of these behavioral symptoms, which include hyperactivity, aggression, tantrums, and self-injury, removes some of the hindrances to other rehabilitative efforts. This article discusses the efficacy and tolerability of various medications and alternative interventions in addressing the symptoms of autism and other PDDs.
Comment in
-
Response to the management of autism and its related disorders.J Clin Psychiatry. 2006 Dec;67(12):2030; author reply 2030-1. doi: 10.4088/jcp.v67n1226a. J Clin Psychiatry. 2006. PMID: 17194285 No abstract available.
Similar articles
-
Pharmacotherapy of irritability in pervasive developmental disorders.Child Adolesc Psychiatr Clin N Am. 2008 Oct;17(4):739-52, vii-viii. doi: 10.1016/j.chc.2008.06.002. Child Adolesc Psychiatr Clin N Am. 2008. PMID: 18775367 Review.
-
Pharmacological treatment options for autism spectrum disorders in children and adolescents.Harv Rev Psychiatry. 2008;16(2):97-112. doi: 10.1080/10673220802075852. Harv Rev Psychiatry. 2008. PMID: 18415882 Review.
-
Role of risperidone in children with autism spectrum disorder.Ann Pharmacother. 2006 May;40(5):909-16. doi: 10.1345/aph.1G389. Epub 2006 Mar 7. Ann Pharmacother. 2006. PMID: 16684811 Review.
-
Managing irritability and aggression in autism spectrum disorders in children and adolescents.Dev Disabil Res Rev. 2010;16(3):258-64. doi: 10.1002/ddrr.118. Dev Disabil Res Rev. 2010. PMID: 20981764 Review.
-
Psychopharmacology of autism spectrum disorders: a selective review.Autism. 2013 Nov;17(6):645-54. doi: 10.1177/1362361312453776. Epub 2012 Aug 14. Autism. 2013. PMID: 22892891 Review.
Cited by
-
A review of complementary and alternative treatments for autism spectrum disorders.Autism Res Treat. 2012;2012:870391. doi: 10.1155/2012/870391. Epub 2012 Nov 28. Autism Res Treat. 2012. PMID: 23243505 Free PMC article.
-
[Psychopharmacology of autism spectrum disorders].Nervenarzt. 2011 May;82(5):582-9. doi: 10.1007/s00115-010-3238-7. Nervenarzt. 2011. PMID: 21484169 Review. German.
-
Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.J Autism Dev Disord. 2010 Mar;40(3):342-51. doi: 10.1007/s10803-009-0878-1. J Autism Dev Disord. 2010. PMID: 19806445
-
Early pharmacological treatment of autism: a rationale for developmental treatment.Biol Psychiatry. 2007 Feb 15;61(4):521-37. doi: 10.1016/j.biopsych.2006.09.021. Biol Psychiatry. 2007. PMID: 17276749 Free PMC article. Review.
-
Individual differences in vulnerability for self-injurious behavior: studies using an animal model.Behav Brain Res. 2011 Feb 2;217(1):148-54. doi: 10.1016/j.bbr.2010.10.012. Epub 2010 Oct 23. Behav Brain Res. 2011. PMID: 20974187 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources